
CING
Healthcare · Biotechnology · $62.5M market cap
$4.30-0.19 (-4.2%)Nov 13, 4:11 PM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · +23.1% over 90 days · 30-day revisions 1 up, 1 down
Beat estimates in 2 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Nov 12, 2026 | Time not confirmed | -0.45 | -0.53 | -18.6% |
| Aug 13, 2026 | Before the open | -0.63 | -0.45 | +28.6% |
| May 14, 2026 | Before the open | -0.53 | -0.95 | -79.2% |
| Mar 18, 2026 | Time not confirmed | -1.55 | -0.84 | +45.8% |
| Nov 13, 2025 | After the close | -0.75 | -1.35 | -80.0% |
| Aug 19, 2025 | Before the open | -0.82 | -1.09 | -32.9% |
| May 8, 2025 | After the close | -0.98 | -1.04 | -6.1% |
| Mar 27, 2025 | Time not confirmed | -2.93 | -3.68 | -25.6% |
| Nov 7, 2024 | Before the open | -2.22 | -1.83 | +17.6% |
| Aug 13, 2024 | Before the open | -4.92 | -5.47 | -11.2% |
| Apr 1, 2024 | Before the open | -52.72 | -19.20 | +63.6% |
| Nov 13, 2023 | After the close | -90.40 | -72.00 | +20.4% |
| Aug 14, 2023 | After the close | -81.60 |
Cingulate Inc., a biopharmaceutical company, develops pharmaceutical products using its drug delivery platform technology for the treatment of attention deficit/hyperactivity disorder (ADHD) and anxiety in the United States. The company's lead product candidate is CTx-1301 (dexmethylphenidate), which is in Phase 3 clinical trials for the treatment of ADHD in children, adolescents, and adults. It also develops…
| -136.80 |
| -67.6% |
| May 10, 2023 | After the close | -77.60 | -84.00 | -8.2% |
| Mar 10, 2023 | After the close | -0.37 | -0.41 | -10.8% |
| Nov 14, 2022 | Before the open | -88.80 | -86.40 | +2.7% |
| Aug 11, 2022 | Before the open | -139.20 | -86.40 | +37.9% |
| May 12, 2022 | After the close | -56.40 | -105.60 | -87.2% |
| Mar 10, 2022 | Before the open | -0.39 | -0.32 | +17.9% |
| Dec 9, 2021 | After the close | 0.00 | -1.38 | — |
| Sep 27, 2021 | Time not confirmed | — | -0.35 | — |